<DOC>
<DOCNO>EP-0648128</DOCNO> 
<TEXT>
<INVENTION-TITLE>
DNA ENCODING PRECURSOR INTERLEUKIN 1-g(b) CONVERTING ENZYME.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K39395	A61K39395	A61K4800	A61K4800	C07H2100	C07H2104	C12N964	C12N964	C12N1509	C12N1509	G01N3000	G01N3088	G01N33577	G01N33577	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	C07H	C07H	C12N	C12N	C12N	C12N	G01N	G01N	G01N	G01N	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K39	A61K39	A61K48	A61K48	C07H21	C07H21	C12N9	C12N9	C12N15	C12N15	G01N30	G01N30	G01N33	G01N33	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Complementary DNA (cDNA) encoding the precursor interleukin-1 beta (pre-IL-1 beta ) converting enzyme (ICE) is isolated from a cDNA library. A cDNA, encoding the full-length open reading frame (ORF) for the nascent ICE, as well as individual cDNAs encoding the 20 kDa subunit and the 10 kDa subunit of ICE are identified and sequenced. ICE is useful in the conversion of pre-IL-1 beta  into mature IL-1 beta . The recombinantly produced ICE, including the individual 20 kDa and 10 kDa subunits is useful in the diagnosis of inflammatory diseases, in the production of recombinant IL-1 beta , and to identify inhibitors of ICE activity.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
MERCK 
&
 CO INC
</APPLICANT-NAME>
<APPLICANT-NAME>
MERCK 
&
 CO INC
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
CALAYCAY JIMMY R
</INVENTOR-NAME>
<INVENTOR-NAME>
HOWARD ANDREW D
</INVENTOR-NAME>
<INVENTOR-NAME>
MILLER DOUGLAS K
</INVENTOR-NAME>
<INVENTOR-NAME>
MOLINEAUX SUSAN M
</INVENTOR-NAME>
<INVENTOR-NAME>
TOCCI MICHAEL J
</INVENTOR-NAME>
<INVENTOR-NAME>
CALAYCAY JIMMY R
</INVENTOR-NAME>
<INVENTOR-NAME>
HOWARD ANDREW D
</INVENTOR-NAME>
<INVENTOR-NAME>
MILLER DOUGLAS K
</INVENTOR-NAME>
<INVENTOR-NAME>
MOLINEAUX SUSAN M
</INVENTOR-NAME>
<INVENTOR-NAME>
TOCCI MICHAEL J
</INVENTOR-NAME>
</INVENTORS>
<DESCRIPTION>
TITLE OF THE INVENTIONDNA ENCODING PRECURSOR INTERLEUKIN lβCONVERTING ENZYMERELATED APPLICATIONSThis application is a continuation-in-part of application serial number 746,454 filed August 16, 1991.BACKGROUND OF THE INVENTION Mammalian interleukin-1 (IL-1) is an immuno- regulatory protein secreted by certain cell types as part of the general inflammatory response. The primary cell type responsible for IL-1 production is the peripheral blood monocyte. Other non- transformed cell types have, however, been described as releasing or containing IL-1 or IL-1-like molecules. These include epithelial cells (Luger et al., J. Immunol. 127: 1493-1498 [1981], Le et al., . Immunol. 138: 2520-2526 [1987] and Lovett and Larsen, J. Clin. Invest. 82: 1 15-122 [1988], connective tissue cells (Ollivierre et al., Biochem. Biophys. Res. Comm. Hi: 904-911 [1986], Le et al, J. Immunol. 138: 2520-2526 [1987], cells of neuronal origin (Giulian et al-, J- Exp. Med.164: 594-604 [1986] and leukocytes (Pistoia et al., J. Immunol. 136: 1688-1692 [1986], Acres et al., Mol. Immuno. 24: 479-485 [1987], Acres et aL, J. Immunol. 138: 2132-2136 [1987] and Lindemann et ah, J. Immunol. 140: 837-839 [1988]. Transformed cell lines have also been shown to produce IL-1. These include monocytic leukemia lines P388D, J774, THP.l , U-937 (Krakauer and Oppenheimer, Cell. Immunol. 80: 223-229 [1983] and Matsushima et al-, Biochem. 25: 3242-3429 [1986], EBV- transformed human B lymphoblastoid lines (Acres, et aL, J. Immunol. 138: 2132-2136 [1987]) and transformed murine keratinocytes (Luger et aL, J. Immunol. 125: 2147-2152 [1982]). 

 Biologically active IL-1 exists in two distinct forms, IL- l with an isoelectric point of about 5.2 and DL-lβ with an isoelectric point of about 7.0 with both forms having a molecular mass of about 17,500 (Bayne et al., J. Exp. Med. 163: 1267-1280 [1986] and Schmidt, J. Exp. Med. 160: 772 [1984]). The polypeptides appear evolutionarily conserved, showing about 27- 33% homology at the amino acid level (Clark et al., Nucleic Acids Res. 14: 7897-7914 [1986]).Mammalian IL-lβ is synthesized as a cell associated precursor polypeptide of about 31.5 kDa (Limjuco et aL, Proc. Natl. Acad. Sci. USA 83: 3972-3976 [1986]). Precursor IL-lβ is unable to bind to IL-1 receptors and is biologically inactive (Mosley et aL, J. Biol. Chem. 262: 2941-2944 [1987]). Biological activity appears dependent upon some form of proteolytic processing which results in the conversion of the precursor 31.5 kDA form to the mature 17.5 kDa form.Recent
</DESCRIPTION>
<CLAIMS>
WHAT IS CLAIMED IS:
1. A DNA molecule which encodes the complete unmodified form of precursor interleukin 1 beta converting enzyme, having the nucleotide sequence:
GCCATGGC CGACAAGGTC CTGAAGGAGA AGAGAAAGCT GTTTATCCGT TCCATGGGTG AAGGTACAAT AAATGGCTTA CTGGATGAAT TATTACAGAC AAGGGTGCTG AACAAGGAAG AGATGGAGAA AGTAAAACGT GAAAATGCTA CAGTTATGGA TAAGACCCGA GCTTTGATTG ACTCCGTTAT TCCGAAAGGG GCACAGGCAT GCCAAATTTG CATCACATAC ATTTGTGAAG AAGACAGTTA CCTGGCAGGG ACGCTGGGAC TCTCAGCAGA TCAAACATCT GGAAATTACC TTAATATGCA AGACTCTCAA GGAGTACTTT CTTCCTTTCC AGCTCCTCAG GCAGTGCAGG ACAACCCAGC TATGCCCACA TCCTCAGGCT CAGAAGGGAA TGTCAAGCTT TGCTCCCTAG AAGAAGCTCA AAGGATATGG AAACAAAAGT CGGCAGAGAT TTATCCAATA ATGGACAAGT CAAGCCGCAC ACGTCTTGCT CTCATTATCT GCAATGAAGA ATTTGACAGT ATTCCTAGAA GAACTGGAGC TGAGGTTGAC ATCACAGGCA TGACAATGCT GCTACAAAAT CTGGGGTACA GCGTAGATGT GAAAAAAAAT CTCACTGCTT CGGACATGAC TACAGAGCTG GAGGCATTTG CACACCGCCC AGAGCACAAG ACCTCTGACA GCACGTTCCT GGTGTTCATG TCTCATGGTA TTCGGGAAGG CATTTGTGGG AAGAAACACT CTGAGCAAGT CCCAGATATA CTACAACTCA 


 ATGCAATCTT TAACATGTTG AATACCAAGA ACTGCCCAAG TTTGAAGGAC AAACCGAAGG TGATCATCAT CCAGGCCTGC CGTGGTGACA GCCCTGGTGT GGTGTGGTTT AAAGATTCAG TAGGAGTTTC TGGAAACCTA TCTTTACCAA CTACAGAAGA GTTTGAGGAT GATGCTATTA AGAAAGCCCA CATAGAGAAG GATTTTATCG CTTTCTGCTC TTCCACACCA GATAATGTTT CTTGGAGACA TCCCACAATG GGCTCTGTTT TTATTGGAAG ACTCATTGAA CATATGCAAG AATATGCCTG TTCCTGTGAT GTGGAGGAAA TTTTCCGCAA GGTTCGATTT TCATTTGAGC AGCCAGATGG TAGAGCGCAG ATGCCCACCA CTGAAAGAGT GACTTTGACA AGATGTTTCT ACCTCTTCCC AGGACATTAA AATAAGGAAA CTGTATGAAT GTCTGTGGGC AGGTACATGT GTATGGTCGG GAGTGTGGGA AGGTTGAGGA AAGGGTACTG AAAGTCCATT TGAGTCAAGA ACTCTAGGTT TACAGGCTGA GAATCCTTAA TCCAAAAAAT TCGAATTTTG AAATGCTCTA AAATCCAACA CTGTGTGAGC GCCCACATGA TATTCAAAGG AAATGTTTAT TGAAACATTT
CAAATTATAG GTTTTTGGAT TAGGGATGCT AAACCAGTAA GTATACAGCT.
(SEQ.ID.NO. :9)
2. A DNA molecule which encodes the 22 kDa protein of precursor interleukin 1 beta converting enzyme, having the nucleotide sequence: 


 TCTCAA GGAGTACTTT CTTCCTTTCC AGCTCCTCAG GCAGTGCAGG ACAACCCAGC TATGCCCACA TCCTCAGGCT CAGAAGGGAA TGTCAAGCTT TGCTCCCTAG AAGAAGCTCA AAGGATATGG AAACAAAAGT CGGCAGAGAT TTATCCAATA ATGGACAAGT CAAGCCGCAC ACGTCTTGCT CTCATTATCT GCAATGAAGA ATTTGACAGT ATTCCTAGAA GAACTGGAGC TGAGGTTGAC ATCACAGGCA TGACAATGCT GCTACAAAAT CTGGGGTACA GCGTAGATGT GAAAAAAAAT CTCACTGCTT CGGACATGAC TACAGAGCTG GAGGCATTTG CACACCGCCC AGAGCACAAG ACCTCTGACA GCACGTTCCT GGTGTTCATG TCTCATGGTA TTCGGGAAGG CATTTGTGGG AAGAAACACT CTGAGCAAGT CCCAGATATA CTACAACTCA ATGCAATCTT TAACATGTTG AATACCAAGA ACTGCCCAAG TTTGAAGGAC AAACCGAAGG TGATCATCAT CCAGGCCTGC CGTGGTGACA GCCCTGGTGT GGTGTGGTTT AAAGAT. (SEQ.ID.NO. :13)
3. A DNA molecule which encodes the 20 kDa subunit of precursor interleukin 1 beta converting enzyme, having the nucleotide sequence :
AACCCAGC TATGCCCACA TCCTCAGGCT CAGAAGGGAA TGTCAAGCTT TGCTCCCTAG AAGAAGCTCA AAGGATATGG AAACAAAAGT CGGCAGAGAT TTATCCAATA ATGGACAAGT CAAGCCGCAC ACGTCTTGCT CTCATTATCT GCAATGAAGA ATTTGACAGT ATTCCTAGAA 


 GAACTGGAGC TGAGGTTGAC ATCACAGGCA TGACAATGCT GCTACAAAAT CTGGGGTACA GCGTAGATGT GAAAAAAAAT CTCACTGCTT CGGACATGAC TACAGAGCTG GAGGCATTTG CACACCGCCC AGAGCACAAG ACCTCTGACA GCACGTTCCT GGTGTTCATG TCTCATGGTA TTCGGGAAGG CATTTGTGGG AAGAAACACT CTGAGCAAGT CCCAGATATA CTACAACTCA ATGCAATCTT TAACATGTTG AATACCAAGA ACTGCCCAAG TTTGAAGGAC AAACCGAAGG TGATCATCAT CCAGGCCTGC CGTGGTGACA GCCCTGGTGT GGTGTGGTTT AAAGAT. (SEQ.ID.NO. :14)
4. A DNA molecule which encodes the 10 kDa subunit of precursor interleukin 1 beta converting, having the nucleotide sequence:
GCTATTA AGAAAGCCCA CATAGAGAAG GATTTTATCG CTTTCTGCTC TTCCACACCA GATAATGTTT CTTGGAGACA TCCCACAATG GGCTCTGTTT TTATTGGAAG ACTCATTGAA CATATGCAAG AATATGCCTG TTCCTGTGAT GTGGAGGAAA TTTTCCGCAA GGTTCGATTT TCATTTGAGC AGCCAGATGG TAGAGCGCAG ATGCCCACCA CTGAAAGAGT GACTTTGACA AGATGTTTCT ACCTCTTCCC AGGACAT . (SEQ.ID.NO. :15) 


 5. An expression vector for the expression of cloned genes in a recombinant host, the expression vector containing one or more cloned genes with a nucleotide sequence selected from the group consisting of:
GCCATGGC CGACAAGGTC CTGAAGGAGA AGAGAAAGCT GTTTATCCGT TCCATGGGTG AAGGTACAAT AAATGGCTTA CTGGATGAAT TATTACAGAC AAGGGTGCTG AACAAGGAAG AGATGGAGAA AGTAAAACGT GAAAATGCTA CAGTTATGGA TAAGACCCGA GCTTTGATTG ACTCCGTTAT TCCGAAAGGG GCACAGGCAT GCCAAATTTG CATCACATAC ATTTGTGAAG AAGACAGTTA CCTGGCAGGG ACGCTGGGAC TCTCAGCAGA TCAAACATCT GGAAATTACC TTAATATGCA AGACTCTCAA GGAGTACTTT CTTCCTTTCC AGCTCCTCAG GCAGTGCAGG ACAACCCAGC TATGCCCACA TCCTCAGGCT CAGAAGGGAA TGTCAAGCTT TGCTCCCTAG AAGAAGCTCA AAGGATATGG AAACAAAAGT CGGCAGAGAT TTATCCAATA ATGGACAAGT CAAGCCGCAC ACGTCTTGCT CTCATTATCT GCAATGAAGA ATTTGACAGT ATTCCTAGAA GAACTGGAGC TGAGGTTGAC ATCACAGGCA TGACAATGCT GCTACAAAAT CTGGGGTACA GCGTAGATGT GAAAAAAAAT CTCACTGCTT CGGACATGAC TACAGAGCTG GAGGCATTTG CACACCGCCC AGAGCACAAG ACCTCTGACA GCACGTTCCT GGTGTTCATG TCTCATGGTA TTCGGGAAGG CATTTGTGGG AAGAAACACT CTGAGCAAGT CCCAGATATA CTACAACTCA ATGCAATCTT TAACATGTTG AATACCAAGA 


 ACTGCCCAAG TTTGAAGGAC AAACCGAAGG TGATCATCAT CCAGGCCTGC CGTGGTGACA GCCCTGGTGT GGTGTGGTTT AAAGATTCAG TAGGAGTTTC TGGAAACCTA TCTTTACCAA CTACAGAAGA GTTTGAGGAT GATGCTATTA AGAAAGCCCA CATAGAGAAG GATTTTATCG CTTTCTGCTC TTCCACACCA GATAATGTTT CTTGGAGACA TCCCACAATG GGCTCTGTTT TTATTGGAAG ACTCATTGAA CATATGCAAG
10 AATATGCCTG TTCCTGTGAT GTGGAGGAAA TTTTCCGCAA GGTTCGATTT TCATTTGAGC AGCCAGATGG TAGAGCGCAG ATGCCCACCA CTGAAAGAGT GACTTTGACA AGATGTTTCT ACCTCTTCCC AGGACATTAA AATAAGGAAA
15 CTGTATGAAT GTCTGTGGGC AGGTACATGT GTATGGTCGG GAGTGTGGGA AGGTTGAGGA AAGGGTACTG AAAGTCCATT TGAGTCAAGA ACTCTAGGTT TACAGGCTGA GAATCCTTAA TCCAAAAAAT TCGAATTTTG AAATGCTCTA
20 AAATCCAACA CTGTGTGAGC GCCCACATGA TATTCAAAGG AAATGTTTAT TGAAACATTT CAAATTATAG GTTTTTGGAT TAGGGATGCT AAACCAGTAA GTATACAGCT (SEQ.ID.NO. :9) , or
25
TCTCAA GGAGTACTTT CTTCCTTTCC AGCTCCTCAG GCAGTGCAGG ACAACCCAGC TATGCCCACA TCCTCAGGCT CAGAAGGGAA TGTCAAGCTT TGCTCCCTAG
30 AAGAAGCTCA AAGGATATGG AAACAAAAGT CGGCAGAGAT TTATCCAATA ATGGACAAGT CAAGCCGCAC ACGTCTTGCT CTCATTATCT 


 GCAATGAAGA ATTTGACAGT ATTCCTAGAA GAACTGGAGC TGAGGTTGAC ATCACAGGCA TGACAATGCT GCTACAAAAT CTGGGGTACA GCGTAGATGT GAAAAAAAAT CTCACTGCTT CGGACATGAC TACAGAGCTG GAGGCATTTG CACACCGCCC AGAGCACAAG ACCTCTGACA GCACGTTCCT GGTGTTCATG TCTCATGGTA TTCGGGAAGG CATTTGTGGG AAGAAACACT CTGAGCAAGT CCCAGATATA CTACAACTCA
10 ATGCAATCTT TAACATGTTG AATACCAAGA ACTGCCCAAG TTTGAAGGAC AAACCGAAGG TGATCATCAT CCAGGCCTGC CGTGGTGACA GCCCTGGTGT GGTGTGGTTT AAAGAT, or (SEQ.ID.NO. :13)
15
AACCCAGC TATGCCCACA TCCTCAGGCT CAGAAGGGAA TGTCAAGCTT TGCTCCCTAG AAGAAGCTCA AAGGATATGG AAACAAAAGT CGGCAGAGAT TTATCCAATA ATGGACAAGT
20 CAAGCCGCAC ACGTCTTGCT CTCATTATCT GCAATGAAGA ATTTGACAGT ATTCCTAGAA GAACTGGAGC TGAGGTTGAC ATCACAGGCA TGACAATGCT GCTACAAAAT CTGGGGTACA GCGTAGATGT GAAAAAAAAT CTCACTGCTT
25 CGGACATGAC TACAGAGCTG GAGGCATTTG CACACCGCCC AGAGCACAAG ACCTCTGACA GCACGTTCCT GGTGTTCATG TCTCATGGTA TTCGGGAAGG CATTTGTGGG AAGAAACACT CTGAGCAAGT CCCAGATATA CTACAACTCA
30 ATGCAATCTT TAACATGTTG AATACCAAGA ACTGCCCAAG TTTGAAGGAC AAACCGAAGG TGATCATCAT CCAGGCCTGC CGTGGTGACA 


 GCCCTGGTGT GGTGTGGTTT AAAGAT, or (SEQ.ID.NO. :14)
GCTATTA AGAAAGCCCA CATAGAGAAG GATTTTATCG CTTTCTGCTC TTCCACACCA GATAATGTTT CTTGGAGACA TCCCACAATG GGCTCTGTTT TTATTGGAAG ACTCATTGAA CATATGCAAG AATATGCCTG TTCCTGTGAT GTGGAGGAAA TTTTCCGCAA GGTTCGATTT TCATTTGAGC AGCCAGATGG TAGAGCGCAG ATGCCCACCA CTGAAAGAGT GACTTTGACA AGATGTTTCT ACCTCTTCCC AGGACAT (SEQ.ID.NO. :15)
6. A recombinant host cell containing one or more recombinantly cloned genes, the recombinantly cloned genes having a nucleotide sequence selected from the group consisting of:
GCCATGGC CGACAAGGTC CTGAAGGAGA AGAGAAAGCT GTTTATCCGT TCCATGGGTG AAGGTACAAT AAATGGCTTA CTGGATGAAT TATTACAGAC AAGGGTGCTG AACAAGGAAG AGATGGAGAA AGTAAAACGT GAAAATGCTA CAGTTATGGA TAAGACCCGA GCTTTGATTG ACTCCGTTAT TCCGAAAGGG GCACAGGCAT GCCAAATTTG CATCACATAC ATTTGTGAAG AAGACAGTTA CCTGGCAGGG ACGCTGGGAC TCTCAGCAGA TCAAACATCT GGAAATTACC TTAATATGCA AGACTCTCAA GGAGTACTTT CTTCCTTTCC AGCTCCTCAG GCAGTGCAGG ACAACCCAGC TATGCCCACA TCCTCAGGCT CAGAAGGGAA TGTCAAGCTT TGCTCCCTAG 


 AAGAAGCTCA AAGGATATGG AAACAAAAGT CGGCAGAGAT TTATCCAATA ATGGACAAGT CAAGCCGCAC ACGTCTTGCT CTCATTATCT GCAATGAAGA ATTTGACAGT ATTCCTAGAA GAACTGGAGC TGAGGTTGAC ATCACAGGCA TGACAATGCT GCTACAAAAT CTGGGGTACA GCGTAGATGT GAAAAAAAAT CTCACTGCTT CGGACATGAC TACAGAGCTG GAGGCATTTG CACACCGCCC AGAGCACAAG ACCTCTGACA
10 GCACGTTCCT GGTGTTCATG TCTCATGGTA TTCGGGAAGG CATTTGTGGG AAGAAACACT CTGAGCAAGT CCCAGATATA CTACAACTCA ATGCAATCTT TAACATGTTG AATACCAAGA ACTGCCCAAG TTTGAAGGAC AAACCGAAGG
15 TGATCATCAT CCAGGCCTGC CGTGGTGACA GCCCTGGTGT GGTGTGGTTT AAAGATTCAG TAGGAGTTTC TGGAAACCTA TCTTTACCAA CTACAGAAGA GTTTGAGGAT GATGCTATTA AGAAAGCCCA CATAGAGAAG GATTTTATCG
20 CTTTCTGCTC TTCCACACCA GATAATGTTT CTTGGAGACA TCCCACAATG GGCTCTGTTT TTATTGGAAG ACTCATTGAA CATATGCAAG AATATGCCTG TTCCTGTGAT GTGGAGGAAA TTTTCCGCAA GGTTCGATTT TCATTTGAGC
25 AGCCAGATGG TAGAGCGCAG ATGCCCACCA CTGAAAGAGT GACTTTGACA AGATGTTTCT ACCTCTTCCC AGGACATTAA AATAAGGAAA CTGTATGAAT GTCTGTGGGC AGGTACATGT GTATGGTCGG GAGTGTGGGA AGGTTGAGGA
30 AAGGGTACTG AAAGTCCATT TGAGTCAAGA ACTCTAGGTT TACAGGCTGA GAATCCTTAA TCCAAAAAAT TCGAATTTTG AAATGCTCTA 


 AAATCCAACA CTGTGTGAGC GCCCACATGA TATTCAAAGG AAATGTTTAT TGAAACATTT CAAATTATAG GTTTTTGGAT TAGGGATGCT AAACCAGTAA GTATACAGCT (SEQ.ID.NO. :9) , or
TCTCAA GGAGTACTTT CTTCCTTTCC AGCTCCTCAG GCAGTGCAGG ACAACCCAGC TATGCCCACA TCCTCAGGCT
10 CAGAAGGGAA TGTCAAGCTT TGCTCCCTAG AAGAAGCTCA AAGGATATGG AAACAAAAGT CGGCAGAGAT TTATCCAATA ATGGACAAGT CAAGCCGCAC ACGTCTTGCT CTCATTATCT GCAATGAAGA ATTTGACAGT ATTCCTAGAA
15 GAACTGGAGC TGAGGTTGAC ATCACAGGCA TGACAATGCT GCTACAAAAT CTGGGGTACA GCGTAGATGT GAAAAAAAAT CTCACTGCTT CGGACATGAC TACAGAGCTG GAGGCATTTG CACACCGCCC AGAGCACAAG ACCTCTGACA
20 GCACGTTCCT GGTGTTCATG TCTCATGGTA TTCGGGAAGG CATTTGTGGG AAGAAACACT CTGAGCAAGT CCCAGATATA CTACAACTCA ATGCAATCTT TAACATGTTG AATACCAAGA ACTGCCCAAG TTTGAAGGAC AAACCGAAGG
25 TGATCATCAT CCAGGCCTGC CGTGGTGACA GCCCTGGTGT GGTGTGGTTT AAAGAT, or (SEQ.ID.NO. :13)
AACCCAGC TATGCCCACA TCCTCAGGCT
30 CAGAAGGGAA TGTCAAGCTT TGCTCCCTAG AAGAAGCTCA AAGGATATGG AAACAAAAGT CGGCAGAGAT TTATCCAATA ATGGACAAGT 


 - I l l -
CAAGCCGCAC ACGTCTTGCT CTCATTATCT GCAATGAAGA ATTTGACAGT ATTCCTAGAA GAACTGGAGC TGAGGTTGAC ATCACAGGCA TGACAATGCT GCTACAAAAT CTGGGGTACA GCGTAGATGT GAAAAAAAAT CTCACTGCTT CGGACATGAC TACAGAGCTG GAGGCATTTG CACACCGCCC AGAGCACAAG ACCTCTGACA GCACGTTCCT GGTGTTCATG TCTCATGGTA TTCGGGAAGG CATTTGTGGG AAGAAACACT CTGAGCAAGT CCCAGATATA CTACAACTCA ATGCAATCTT TAACATGTTG AATACCAAGA ACTGCCCAAG TTTGAAGGAC AAACCGAAGG TGATCATCAT CCAGGCCTGC CGTGGTGACA GCCCTGGTGT GGTGTGGTTT AAAGAT,or (SEQ.ID.NO. :14)
GCTATTA AGAAAGCCCA CATAGAGAAG GATTTTATCG CTTTCTGCTC TTCCACACCA GATAATGTTT CTTGGAGACA TCCCACAATG GGCTCTGTTT TTATTGGAAG ACTCATTGAA CATATGCAAG AATATGCCTG TTCCTGTGAT GTGGAGGAAA TTTTCCGCAA GGTTCGATTT TCATTTGAGC AGCCAGATGG TAGAGCGCAG ATGCCCACCA CTGAAAGAGT GACTTTGACA AGATGTTTCT ACCTCTTCCC AGGACAT . (SEQ.ID.NO. :15)
7. A recombinant host cell expressing recombinant interleukin 1 beta and containing one or more recombinant genes selected from the group consisting of:
GCCATGGC CGACAAGGTC CTGAAGGAGA 


 AGAGAAAGCT GTTTATCCGT TCCATGGGTG AAGGTACAAT AAATGGCTTA CTGGATGAAT TATTACAGAC AAGGGTGCTG AACAAGGAAG AGATGGAGAA AGTAAAACGT GAAAATGCTA CAGTTATGGA TAAGACCCGA GCTTTGATTG ACTCCGTTAT TCCGAAAGGG GCACAGGCAT GCCAAATTTG CATCACATAC ATTTGTGAAG AAGACAGTTA CCTGGCAGGG ACGCTGGGAC TCTCAGCAGA TCAAACATCT GGAAATTACC
10 TTAATATGCA AGACTCTCAA GGAGTACTTT CTTCCTTTCC AGCTCCTCAG GCAGTGCAGG ACAACCCAGC TATGCCCACA TCCTCAGGCT CAGAAGGGAA TGTCAAGCTT TGCTCCCTAG AAGAAGCTCA AAGGATATGG AAACAAAAGT
15 CGGCAGAGAT TTATCCAATA ATGGACAAGT CAAGCCGCAC ACGTCTTGCT CTCATTATCT GCAATGAAGA ATTTGACAGT ATTCCTAGAA GAACTGGAGC TGAGGTTGAC ATCACAGGCA TGACAATGCT GCTACAAAAT CTGGGGTACA
20 GCGTAGATGT GAAAAAAAAT CTCACTGCTT CGGACATGAC TACAGAGCTG GAGGCATTTG CACACCGCCC AGAGCACAAG ACCTCTGACA GCACGTTCCT GGTGTTCATG TCTCATGGTA TTCGGGAAGG CATTTGTGGG AAGAAACACT
25 CTGAGCAAGT CCCAGATATA CTACAACTCA ATGCAATCTT TAACATGTTG AATACCAAGA ACTGCCCAAG TTTGAAGGAC AAACCGAAGG TGATCATCAT CCAGGCCTGC CGTGGTGACA GCCCTGGTGT GGTGTGGTTT AAAGATTCAG
30 TAGGAGTTTC TGGAAACCTA TCTTTACCAA CTACAGAAGA GTTTGAGGAT GATGCTATTA AGAAAGCCCA CATAGAGAAG GATTTTATCG 


 CTTTCTGCTC TTCCACACCA GATAATGTTT CTTGGAGACA TCCCACAATG GGCTCTGTTT TTATTGGAAG ACTCATTGAA CATATGCAAG AATATGCCTG TTCCTGTGAT GTGGAGGAAA TTTTCCGCAA GGTTCGATTT TCATTTGAGC AGCCAGATGG TAGAGCGCAG ATGCCCACCA CTGAAAGAGT GACTTTGACA AGATGTTTCT ACCTCTTCCC AGGACATTAA AATAAGGAAA CTGTATGAAT GTCTGTGGGC AGGTACATGT
10 GTATGGTCGG GAGTGTGGGA AGGTTGAGGA AAGGGTACTG AAAGTCCATT TGAGTCAAGA ACTCTAGGTT TACAGGCTGA GAATCCTTAA TCCAAAAAAT TCGAATTTTG AAATGCTCTA AAATCCAACA CTGTGTGAGC GCCCACATGA
15 TATTCAAAGG AAATGTTTAT TGAAACATTT CAAATTATAG GTTTTTGGAT TAGGGATGCT AAACCAGTAA GTATACAGCT (SEQ.ID.NO. :9) , or
20 TCTCAA GGAGTACTTT CTTCCTTTCC AGCTCCTCAG GCAGTGCAGG ACAACCCAGC TATGCCCACA TCCTCAGGCT CAGAAGGGAA TGTCAAGCTT TGCTCCCTAG AAGAAGCTCA AAGGATATGG AAACAAAAGT
25 CGGCAGAGAT TTATCCAATA ATGGACAAGT CAAGCCGCAC ACGTCTTGCT CTCATTATCT GCAATGAAGA ATTTGACAGT ATTCCTAGAA GAACTGGAGC TGAGGTTGAC ATCACAGGCA TGACAATGCT GCTACAAAAT CTGGGGTACA
30 GCGTAGATGT GAAAAAAAAT CTCACTGCTT CGGACATGAC TACAGAGCTG GAGGCATTTG CACACCGCCC AGAGCACAAG ACCTCTGACA 


 GCACGTTCCT GGTGTTCATG TCTCATGGTA TTCGGGAAGG CATTTGTGGG AAGAAACACT CTGAGCAAGT CCCAGATATA CTACAACTCA ATGCAATCTT TAACATGTTG AATACCAAGA ACTGCCCAAG TTTGAAGGAC AAACCGAAGG TGATCATCAT CCAGGCCTGC CGTGGTGACA GCCCTGGTGT GGTGTGGTTT AAAGAT, or (SEQ.ID.NO. :13)
10 AACCCAGC TATGCCCACA TCCTCAGGCT CAGAAGGGAA TGTCAAGCTT TGCTCCCTAG AAGAAGCTCA AAGGATATGG AAACAAAAGT CGGCAGAGAT TTATCCAATA ATGGACAAGT CAAGCCGCAC ACGTCTTGCT CTCATTATCT
15 GCAATGAAGA ATTTGACAGT ATTCCTAGAA GAACTGGAGC TGAGGTTGAC ATCACAGGCA TGACAATGCT GCTACAAAAT CTGGGGTACA GCGTAGATGT GAAAAAAAAT CTCACTGCTT CGGACATGAC TACAGAGCTG GAGGCATTTG
20 CACACCGCCC AGAGCACAAG ACCTCTGACA GCACGTTCCT GGTGTTCATG TCTCATGGTA TTCGGGAAGG CATTTGTGGG AAGAAACACT CTGAGCAAGT CCCAGATATA CTACAACTCA ATGCAATCTT TAACATGTTG AATACCAAGA
25 ACTGCCCAAG TTTGAAGGAC AAACCGAAGG TGATCATCAT CCAGGCCTGC CGTGGTGACA GCCCTGGTGT GGTGTGGTTT AAAGAT,or (SEQ.ID.NO. :14)
30 


 GCTATTA AGAAAGCCCA CATAGAGAAG GATTTTATCG CTTTCTGCTC TTCCACACCA GATAATGTTT CTTGGAGACA TCCCACAATG GGCTCTGTTT TTATTGGAAG ACTCATTGAA CATATGCAAG AATATGCCTG TTCCTGTGAT GTGGAGGAAA TTTTCCGCAA GGTTCGATTT TCATTTGAGC AGCCAGATGG TAGAGCGCAG ATGCCCACCA CTGAAAGAGT GACTTTGACA AGATGTTTCT ACCTCTTCCC AGGACAT . (SEQ.ID.NO. :15)
8. A protein, in substanitally pure form which can specifically cleave precursor IL-1 beta to form mature IL-1 beta, having an amino acid sequence:
Met Ala Asp Lys Val Leu Lys Glu Lys Arg Lys Leu Phe He Arg Ser Met Gly Glu Gly Thr He Asn Gly Leu Leu Asp Glu Leu Leu Gin Thr Arg Val Leu Asn Lys Glu Glu Met Glu Lys Val Lys Arg Glu Asn Ala Thr Val Met Asp Lys Thr Arg Ala Leu He Asp Ser Val He Pro Lys Gly Ala Gin Ala Cys Gin He Cys He Thr Tyr He Cys Glu Glu Asp Ser Tyr Leu Ala Gly Thr Leu Gly Leu Ser Ala Asp Gin Thr Ser Gly Asn Tyr Leu Asn Met Gin Asp Ser Gin Gly Val Leu Ser Ser Phe Pro Ala Pro Gin Ala Val Gin Asp Asn Pro Ala Met Pro Thr Ser Ser Gly Ser Glu Gly Asn Val Lys Leu Cys Ser Leu Glu Glu Ala Gin Arg He Trp Lys Gin Lys Ser Ala Glu He Tyr Pro He Met Asp Lys Ser Ser Arg Thr Arg Leu Ala Leu He He Cys Asn Glu Glu Phe Asp Ser He Pro Arg Arg Thr Gly Ala Glu Val Asp He Thr Gly Met Thr Met Leu Leu Gin Asn Leu Gly Tyr Ser Val Asp Val Lys Lys Asn Leu Thr Ala 



Ser Asp Met Thr Thr Glu Leu Glu Ala Phe Ala His Arg
Pro Glu His Lys Thr Ser Asp Ser Thr Phe Leu Val Phe
Met Ser His Gly He Arg Glu Gly He Cys Gly Lys Lys
His Ser Glu Gin Val Pro Asp He Leu Gin Leu Asn Ala
He Phe Asn Met Leu Asn Thr Lys Asn Cys Pro Ser Leu
Lys Asp Lys Pro Lys Val He He He Gin Ala Cys Arg
Gly Asp Ser Pro Gly Val Val Trp Phe Lys Asp Ser Val
Gly Val Ser Gly Asn Leu Ser Leu Pro Thr Thr Glu Glu
Phe Glu Asp Asp Ala He Lys Lys Ala His He Glu Lys
Asp Phe He Ala Phe Cys Ser Ser Thr Pro Asp Asn Val
Ser Trp Arg His Pro Thr Met Gly Ser Val Phe He Gly
Arg Leu He Glu His Met Gin Glu Tyr Ala Cys Ser Cys
Asp Val Glu Glu He Phe Arg Lys Val Arg Phe Ser Phe Glu Gin Pro Asp Gly Arg Ala Gin Met Pro Thr Thr Glu
Arg Val Thr Leu Thr Arg Cys Phe Tyr Leu Phe Pro Gly His. (SEQ.ID.NO. :10)
9. A protein in substantially pure form which conesponds to the 22 kDa subunit of precursor interleukin 1 beta converting enzyme, having the amino acid sequence:
Asp Ser Gin Gly Val Leu Ser Ser Phe Pro Ala Pro Gin Ala Val Gin Asp Asn Pro Ala Met Pro Thr Ser Ser Gly Ser Glu Gly Asn Val Lys Leu Cys Ser Leu Glu Glu Ala Gin Arg He Trp Lys Gin Lys Ser Ala Glu He Tyr Pro He Met Asp Lys Ser Ser Arg Thr Arg Leu Ala Leu He He Cys Asn Glu Glu Phe Asp Ser He Pro Arg Arg Thr Gly Ala Glu Val Asp He Thr Gly Met Thr Met Leu Leu Gin Asn Leu Gly Tyr Ser Val Asp Val Lys Lys Asn Leu Thr Ala Ser Asp Met Thr Thr Glu Leu Glu Ala Phe Ala His Arg Pro Glu His Lys Thr Ser Asp Ser Thr Phe Leu 


 Val Phe Met Ser His Gly He Arg Glu Gly He Cys Gly Lys Lys His Ser Glu Gin Val Pro Asp He Leu Gin Leu Asn Ala He Phe Asn Met Leu Asn Thr Lys Asn Cys Pro Ser Leu Lys Asp Lys Pro Lys Val He He He Gin Ala Cys Arg Gly Asp Ser Pro Gly Val Val Trp Phe Lys Asp, (SEQ.ID.NO. :16)
10. A protein, in substantially pure form which conesponds to the 20 kDa subunit of presursor interleukin 1 beta o converting enzyme, having an amino acid sequence:
R-Pro Ala Met Pro Thr Ser Ser Gly Ser Glu Gly Asn Val Lys Leu Cys Ser Leu Glu Glu Ala Gin Arg He Trp Lys Gin Lys Ser Ala Glu He Tyr Pro He Met Asp Lys 
■
 -" Ser Ser Arg Thr Arg Leu Ala Leu He He Cys Asn Glu Glu Phe Asp Ser He Pro Arg Arg Thr Gly Ala Glu Val Asp He Thr Gly Met Thr Met Leu Leu Gin Asn Leu Gly Tyr Ser Val Asp Val Lys Lys Asn Leu Thr Ala Ser Asp Met Thr Thr Glu Leu Glu Ala Phe Ala His Arg Pro Glu 0 His Lys Thr Ser Asp Ser Thr Phe Leu Val Phe Met Ser His Gly He Arg Glu Gly He Cys Gly Lys Lys His Ser Glu Gin Val Pro Asp He Leu Gin Leu Asn Ala He Phe Asn Met Leu Asn Thr Lys Asn Cys Pro Ser Leu Lys Asp Lys Pro Lys Val He He He Gin Ala Cys Arg Gly Asp 5 Ser Pro Gly Val Val Trp Phe Lys Asp, (SEQ.ID.NO. :17)
wherein R is Asp or Asn.
0
 11. A protein, in substantially pure form which conesponds to the 10 kDa subunit of precursor interleukin 1 beta converting enzyme, having an amino acid sequence: 


Ala He Lys Lys Ala His He Glu Lys Asp Phe He Ala Phe Cys Ser Ser Thr Pro Asp Asn Val Ser Trp Arg His Pro Thr Met Gly Ser Val Phe He Gly Arg Leu He Glu His Met Gin Glu Tyr Ala Cys Ser Cys Asp Val Glu Glu He Phe Arg Lys Val Arg Phe Ser Phe Glu Gin Pro Asp Gly Arg Ala Gin Met Pro Thr Thr Glu Arg Val Thr Leu Thr Arg Cys Phe Tyr Leu Phe Pro Gly His (SEQ.ID.NO. :18)
12. A composite protein molecule, in substantially pure form which can specifically cleave precursor interleukin 1 to form mature interlukin 1 beta, comprising:
(a) a polypeptide having the amino acid
Sequence: R-Asn Pro Ala Met Pro Thr Ser Ser Gly Ser Glu Gly Asn Val Lys Leu Cys Ser Leu Glu Glu Ala Gin Arg He Trp Lys Gin Lys Ser Ala Glu He Tyr Pro He Met Asp Lys Ser Ser Arg Thr Arg Leu Ala Leu He He Cys Asn Glu Glu Phe Asp Ser He Pro Arg Arg Thr Gly Ala Glu Val Asp He Thr Gly Met Thr Met Leu Leu Gin Asn Leu Gly Tyr Ser Val Asp Val Lys Lys Asn Leu Thr Ala Ser Asp Met Thr Thr Glu Leu Glu Ala Phe Ala His Arg Pro Glu His Lys Thr Ser Asp Ser Thr Phe Leu Val Phe Met Ser His Gly He Arg Glu Gly He Cys Gly Lys Lys His Ser Glu Gin Val Pro Asp He Leu Gin Leu Asn Ala He Phe Asn Met Leu Asn Thr Lys Asn Cys Pro Ser Leu Lys Asp Lys Pro Lys Val He He He Gin Ala Cys Arg Gly Asp Ser Pro Gly Val Val Trp Phe Lys Asp, (SEQ.ID.NO. :17)
wherein R is Asp or Asn, and 


 (b) a polypeptide having the amino acid sequence:
Ala He Lys Lys Ala His He Glu Lys Asp Phe He Ala
Phe Cys Ser Ser Thr Pro Asp Asn Val Ser Trp Arg His
Pro Thr Met Gly Ser Val Phe He Gly Arg Leu He Glu
His Met Gin Glu Tyr Ala Cys Ser Cys Asp Val Glu Glu
He Phe Arg Lys Val Arg Phe Ser Phe Glu Gin Pro Asp
Gly Arg Ala Gin Met Pro Thr Thr Glu Arg Val Thr Leu
Thr Arg Cys Phe Tyr Leu Phe Pro Gly His (SEQ.ID.NO. :18)
13. A composite protein molecule, in substantially pure form which can specifically cleave precursor interleukin 1 beta to form mature interleukin 1 beta, comprising:
(a) a polypeptide having the amino acid sequence:
Asp Ser Gin Gly Val Leu Ser Ser Phe Pro Ala Pro Gin Ala Val Gin Asp Asn Pro Ala Met Pro Thr Ser Ser Gly Ser Glu Gly Asn Val Lys Leu Cys Ser Leu Glu Glu Ala Gin Arg He Trp Lys Gin Lys Ser Ala Glu He Tyr Pro He Met Asp Lys Ser Ser Arg Thr Arg Leu Ala Leu He He Cys Asn Glu Glu Phe Asp Ser He Pro Arg Arg Thr Gly Ala Glu Val Asp He Thr Gly Met Thr Met Leu Leu Gin Asn Leu Gly Tyr Ser Val Asp Val Lys Lys Asn Leu Thr Ala Ser Asp Met Thr Thr Glu Leu Glu Ala Phe Ala His Arg Pro Glu His Lys Thr Ser Asp Ser Thr Phe Leu Val Phe Met Ser His Gly He Arg Glu Gly He Cys Gly Lys Lys His Ser Glu Gin Val Pro Asp He Leu Gin Leu Asn Ala He Phe Asn Met Leu Asn Thr Lys Asn Cys Pro Ser Leu Lys Asp Lys Pro Lys Val He He He Gin Ala 


Cys Arg Gly Asp Ser Pro Gly Val Val Trp Phe Lys Asp, (SEQ.ID.NO. :16)
and
(b) a polypeptide having the amino acid sequence:
Ala He Lys Lys Ala His He Glu Lys Asp Phe He Ala Phe Cys Ser Ser Thr Pro Asp Asn Val Ser Trp Arg His Pro Thr Met Gly Ser Val Phe He Gly Arg Leu He Glu His Met Gin Glu Tyr Ala Cys Ser Cys Asp Val Glu Glu He Phe Arg Lys Val Arg Phe Ser Phe Glu Gin Pro Asp Gly Arg Ala Gin Met Pro Thr Thr Glu Arg Val Thr Leu Thr Arg Cys Phe Tyr Leu Phe Pro Gly His (SEQ.ID.NO. :18)
14. A monospecific antibody immunologically reactive with monomeric precursor interleukin 1 beta converting enzyme.
15. The antibody of Claim 11 , wherein the antibody blocks the activity of precursor interleukin 1 beta converting enzyme, and the antibody is a monoclonal antibody.
16. A monospecific antibody immunologically reactive with the 20 kDa subunit of precursor interleukin 1 beta converting enzyme.
17. The antibody of Claim 13, wherein the antibody blocks the activity of precursor interleukin 1 beta converting enzyme, and the antibody is a monoclonal antibody. 



 18. A monospecific antibody immunologically reactive with the 10 kDa subunit of precursor interleukin 1 beta converting enzyme.
19. The antibody of Claim 15, wherein the antibody blocks the activity of precursor interleukin 1 beta converting enzyme, and the antibody is a monoclonal antibody.
20. A recombinant microorganism having the designation ATCC 68655. 

</CLAIMS>
</TEXT>
</DOC>
